Does Marijuana impact Serotonin? The Complex Interplay of Neurochemistry

Marijuana interacts with serotonin on a complex neurochemical level, and is the subject of ongoing research by scientists. THC binds preferentially to the cannabinoid receptors, but still eventually alters serotonin systems indirectly and through complex neural connectomes. The reason for this is that cannabinoid and serotonin receptors are located in overlapping sites in the brain associated with accumulated appetite, mood and sleep.

Indirect modulation of serotonin

Research suggests THC can elevate serotonin levels in some areas of the brain, and reduce in others. The dorsal raphe nucleus, which is the primary production site of serotonin in the brain also has cannabinoid receptors, and each of the neurotransmitter systems are connected in a feedback loop to the compounds found in marijuana.

The issue associated with affect

At low doses it is shown that THC and CBD would both have greater serotonin effects as lowering fever. At high doses of THC the effect is paradoxical, increasing doses may actually bring down serotonin activity, in most cases causing anxiety or some other feelings inconsistent with some mood improvements. This biphasic response explains in part why the influence of marijuana on mood does not seem reliable in relation to use and dosing.

Considerations on chronic use

Chronic use of marijuana might have an effect on baseline serotonin effectiveness. In animal studies chronic THC has impaired serotonin receptors and produced a lowering effect on natural serotonin. Human studies offer little conclusive evidence, some studies suggesting evidence of adaptation of the serotonin system, but not a permanent dysfunction. Neuroplasticity in the brain offers a reasonable expectation that normal serotonin function should return, once stopped.

Therapeutic possibilities

Understanding the interactions of marijuana and serotonin could suggest a therapeutic direction. The influence of CBD on serotonin receptors offers enormous promise for the treatment of depression and anxiety, and less full-antidepressant side effects. Some researchers would note that there may be advantages in using a multi-target agent (marijuana) that operates on the endocannabinoid system and serotonin as a single target agent.

Limitations of research and looking ahead

Research at this point is extremely limited due to the legal status of marijuana, and the challenge of researching multi-system interactions. Most studies of serotonin and marijuana are either in animal models, or use synthetic cannabinoids, neither of which captures the neurochemical interaction someone would experience when using cannabis as it would be in real-world applications. The final metric included to consider is the advances in neuroimaging, which are starting to make sense of the specific processes that are occurring related to serotonin and cannabinoids on either side of the crosstalk.

Face validity in clinical implications

For individuals that are taking medications that influence serotonin, interactions of marijuana and serotonin may require much more consideration, and caution. While it is rare to have the full serotonin syndrome in simple marijuana use, there are serious undesirable outcomes associated with using cannabis with certain antibiotics and certain other medications.